BPMC BLUEPRINT MEDICINES CORP revenue, earnings and financials

For the quarter ended March 31, 2025, BLUEPRINT MEDICINES CORP reported revenue of $149M (up 55.5% from a year earlier), net income of $496K and diluted EPS of $0.01; over the last four quarters revenue was $562M and net income −$156M; for the fiscal year ended December 2024 revenue was $509M, up 104.0% on the year before.

BPMC annual revenue and earnings

• Fiscal year ended Dec 2024: revenue $509M, gross profit n/a, operating income n/a, net income −$67.1M (margin -13.2%), EPS −$1.07
• Fiscal year ended Dec 2023: revenue $249M, gross profit n/a, operating income n/a, net income −$507M (margin -203.3%), EPS −$8.37
• Fiscal year ended Dec 2022: revenue $204M, gross profit n/a, operating income n/a, net income −$558M (margin -273.2%), EPS −$9.35
• Fiscal year ended Dec 2021: revenue $180M, gross profit n/a, operating income n/a, net income −$644M (margin -357.7%), EPS −$11.01

BPMC quarterly revenue and earnings

• Quarter ended Mar 31, 2025: revenue $149M (up 55.5% year over year), net income $496K, EPS $0.01
• Quarter ended Dec 31, 2024 (from the annual report): revenue $146M (up 103.4% year over year), net income −$50.0M, EPS −$0.78
• Quarter ended Sep 30, 2024: revenue $128M (up 126.6% year over year), net income −$56.3M, EPS −$0.89
• Quarter ended Jun 30, 2024: revenue $138M (up 140.0% year over year), net income −$50.0M, EPS −$0.80
• Quarter ended Mar 31, 2024: revenue $96.1M (up 51.9% year over year), net income $89.1M, EPS $1.40
• Quarter ended Dec 31, 2023 (from the annual report): revenue $72.0M (up 85.5% year over year), net income −$111M, EPS −$1.83
• Quarter ended Sep 30, 2023: revenue $56.6M (down 14.3% year over year), net income −$134M, EPS −$2.20
• Quarter ended Jun 30, 2023: revenue $57.6M (up 57.5% year over year), net income −$133M, EPS −$2.19
• Quarter ended Mar 31, 2023: revenue $63.3M (up 0.9% year over year), net income −$130M, EPS −$2.15
• Quarter ended Dec 31, 2022 (from the annual report): revenue $38.8M (down 63.8% year over year), net income −$159M, EPS −$2.65
• Quarter ended Sep 30, 2022: revenue $66.0M (up 172.8% year over year), net income −$133M, EPS −$2.23
• Quarter ended Jun 30, 2022: revenue $36.5M (up 33.9% year over year), net income −$160M, EPS −$2.68
• Quarter ended Mar 31, 2022: revenue $62.7M (up 190.7% year over year), net income −$106M, EPS −$1.79
• Quarter ended Dec 31, 2021 (from the annual report): revenue $107M, net income −$319M, EPS −$5.43
• Quarter ended Sep 30, 2021: revenue $24.2M, net income −$117M, EPS −$2.00
• Quarter ended Jun 30, 2021: revenue $27.3M, net income −$108M, EPS −$1.86
• Quarter ended Mar 31, 2021: revenue $21.6M, net income −$99.7M, EPS −$1.72

BPMC cash flow, buybacks and dividends

• Fiscal year ended Dec 2024: operating cash flow −$193M, share buybacks n/a
• Fiscal year ended Dec 2023: operating cash flow −$437M, share buybacks n/a
• Fiscal year ended Dec 2022: operating cash flow −$502M, share buybacks n/a
• Fiscal year ended Dec 2021: operating cash flow −$299M, share buybacks n/a

BPMC balance sheet

• Mar 31, 2025: cash $122M, total assets $1.20B, total liabilities $853M, shareholders' equity $342M
• Dec 31, 2024: cash $102M, total assets $1.18B, total liabilities $881M, shareholders' equity $299M
• Sep 30, 2024: cash $89.4M, total assets $1.20B, total liabilities $887M, shareholders' equity $313M
• Jun 30, 2024: cash $54.8M, total assets $1.20B, total liabilities $883M, shareholders' equity $320M
• Mar 31, 2024: cash $113M, total assets $1.04B, total liabilities $728M, shareholders' equity $311M
• Dec 31, 2023: cash $71.3M, total assets $1.05B, total liabilities $919M, shareholders' equity $131M
• Sep 30, 2023: cash $56.0M, total assets $1.11B, total liabilities $903M, shareholders' equity $203M
• Jun 30, 2023: cash $75.5M, total assets $1.11B, total liabilities $795M, shareholders' equity $311M

What is BPMC's revenue?

BLUEPRINT MEDICINES CORP reported $562M of revenue over its last four quarters, through March 31, 2025.

Is BPMC profitable?

No. BLUEPRINT MEDICINES CORP lost $156M over the last four quarters.

What is BPMC's EPS?

Diluted earnings per share over the last four quarters were −$2.46; $0.01 in the latest quarter.

BPMC ownership and insider trades · All stocks